The Comorbidity Profile among Chronic Kidney Disease Patients in Clinical Practice: A Prospective Study

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 272

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IAHS-6-1_009

تاریخ نمایه سازی: 3 اسفند 1398

چکیده مقاله:

Background: The comorbidity profile among chronic kidney disease (CKD) patients can influence and predispose them to increase mortalityand health‑care costs. In addition, there could also be a prolongation in the length of hospital stay and recurrent frequency of hospitalization.Aim: This study was predominantly designed to highlight and create awareness concerning the burden of comorbidity profile among CKDpatients in renal practice. Materials and Methods: This was a descriptive prospective study of 18‑month duration that was carried out to reviewthe medical case records of consented adult CKD patients attending a Nigerian Tertiary Kidney Care Hospital from January 2015 to June 2016.Results: This study involved 123 consented adult CKD patients comprising 82 (66.67%) males and 41 (33.33%) females, with a mean ageof 53.81 ± 16.03 years. A majority of the respondents 45 (36.59%) were having 2 comorbidities with hypertension in 103 (83.70%), diabetesmellitus in 39 (31.70%), obesity in 24 (19.51%), heart failure in 11 (8.90%), obstructive uropathy in 8 (6.50%), human immunodeficiencyvirus infection in 7 (5.70%), peptic ulcer disease/gastroesophageal reflux disease in 7 (5.70%), gastroenteritis/gastrointestinal tract sepsisin 6 (4.9%), stroke in 5 (4.10%), adult polycystic kidney disease in 5 (4.10%), and hepatitis B virus infection in 5 (4.10%), being the mostfrequent. Eighty‑six (69.9%) patients were in CKD Stage 5, 15 (12.2%) were in CKD Stage 4, 19 (15.5%) were in CKD Stage 3, 2 (1.6%)in CKD Stage 2, and the remaining one (0.8%) in CKD Stage 1. Regarding the form of nephrological interventions offered, majority of therespondents 66 (53.66%) were on maintenance dialysis, followed by 53 (43.09%) on conservative care, while 4 (3.25%) were on renal grafttransplant. Conclusion: The prevalence rates for comorbidities such as hypertension, diabetes mellitus, and obesity were significantly highamong these CKD patients; this agreed with the previous studies conducted in other regions of the world. In this study, the comorbidity profileamong CKD patients may significantly increase the risk of mortality, recurrent frequency of hospitalization, length of hospital admission,and health‑care costs.

نویسندگان

Olumuyiwa John Fasipe

Department of Clinical Pharmacology and Therapeutics, University of Medical Sciences, Ondo City, Ondo State

Peter Ehizokhale Akhideno

Department of Internal Medicine, Irrua Specialist Teaching Hospital, Irrua

Sampson Omaghbemi Owhin

Department of Internal Medicine, Irrua Specialist Teaching Hospital, Irrua

Fidelis Azaghor Iiuko

Department of Clinical Pharmacology and Therapeutics, Edo University, Iyamho, Edo state, Nigeria

Oluwatosin Beatrice Ibiyemil-Fasipe

Department of Clinical Pharmacology and Therapeutics, University of Medical Sciences, Ondo City, Ondo State